Viewing Study NCT00423592


Ignite Creation Date: 2025-12-24 @ 3:53 PM
Ignite Modification Date: 2026-04-16 @ 12:37 AM
Study NCT ID: NCT00423592
Status: COMPLETED
Last Update Posted: 2013-06-17
First Post: 2007-01-17
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: Phase 2 Study of Ambrisentan for Liver Function Test Rescue in Pulmonary Arterial Hypertension
Sponsor: Gilead Sciences
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: AMB-222
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators